PIK3R1 and neoplasm: It has been reported that PIK3R1 is differentially expressed in many human cancers and is closely related to tumor progression and metastasis (Lin et al., 2015), which make it an important therapeutic target through inhibiting the PI3K/AKT/mTOR pathway (Lahusen et al., 2009).